Growth Metrics

Merck (MRK) Net Margin Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 1,568.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -2,848.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -501.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -5,859.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -12.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 931.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 134.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,859.00
Dec 31, 2025 -590.00
Sep 30, 2025 1,452.00
Jun 30, 2025 -588.00
Mar 31, 2025 253.00
Dec 31, 2024 3,234.00
Sep 30, 2024 -1,078.00
Jun 30, 2024 7,338.00
Mar 31, 2024 1,072.00
Dec 31, 2021 -524.00
Jun 30, 2021 -416.00
Mar 31, 2021 -2,259.00
Dec 31, 2020 4,835.00
Sep 30, 2020 -974.00
Jun 30, 2020 -1,542.00
Mar 31, 2020 24.00
Dec 31, 2019 -5,974.00
Sep 30, 2019 -276.00
Jun 30, 2019 609.00
Mar 31, 2019 1,908.00
Dec 31, 2018 2,612.00
Sep 30, 2018 1,863.00
Jun 30, 2018 -325.00
Mar 31, 2018 -911.00
Dec 31, 2017 -415.00
Sep 30, 2017 -2,126.00
Jun 30, 2017 737.00
Mar 31, 2017 436.00
Dec 31, 2016 -1,542.00
Sep 30, 2016 259.00
Jun 30, 2016 525.00
Mar 31, 2016 197.00
Dec 31, 2015 -6,029.00
Sep 30, 2015 1,020.00
Jun 30, 2015 -1,156.00
Mar 31, 2015 -670.00
Dec 31, 2014 6,270.00
Sep 30, 2014 -245.00
Jun 30, 2014 1,010.00
Mar 31, 2014 172.00
Dec 31, 2013 1,993.00
Sep 30, 2013 -492.00
Jun 30, 2013 -629.00
Mar 31, 2013 8.00
Dec 31, 2012 -555.00
Sep 30, 2012 101.00
Jun 30, 2012 -212.00
Mar 31, 2012 2,701.00
Dec 31, 2011 2,658.00
Sep 30, 2011 3,307.00
Jun 30, 2011 3,148.00
Mar 31, 2011 649.00
Dec 31, 2010 -14,295.00
Sep 30, 2010 -2,661.00
Jun 30, 2010 -2,531.00
Mar 31, 2010 -3,335.00